Literature DB >> 2944480

Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection.

S L Spruance, D J Freeman, N V Sheth.   

Abstract

Topical foscarnet (PFA) and acyclovir (ACV) were compared in the dorsal cutaneous guinea pig model of herpes simplex virus type 1 infection. The relative order of efficacy was PFA cream greater than ACV cream greater than ACV ointment. In vitro studies demonstrated that PFA and ACV formulated in cream vehicles penetrated through guinea pig skin 7- to 10-fold faster than did ACV in ointment.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2944480      PMCID： PMC176467          DOI： 10.1128/AAC.30.1.196

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

1.  Guinea pig model for cutaneous herpes simplex virus infection.

Authors:  W R Hubler; T D Felber; D Troll; M Jarratt
Journal:  J Invest Dermatol       Date:  1974-02       Impact factor: 8.551

Review 2.  Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy.

Authors:  A P Fiddian; G R Kinghorn; D Goldmeier; E Rees; P Rodin; R N Thin; G A de Konig
Journal:  J Antimicrob Chemother       Date:  1983-09       Impact factor: 5.790

Review 3.  Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections.

Authors:  W A Van Vloten; R N Swart; F Pot
Journal:  J Antimicrob Chemother       Date:  1983-09       Impact factor: 5.790

4.  Kinetic analysis in cell culture of the reversal of antiherpes activity of nucleoside analogs by thymidine.

Authors:  A Larsson; G Brännström; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

5.  Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol.

Authors:  S L Spruance; L E Schnipper; J C Overall; E R Kern; B Wester; J Modlin; G Wenerstrom; C Burton; K A Arndt; G L Chiu; C S Crumpacker
Journal:  J Infect Dis       Date:  1982-07       Impact factor: 5.226

6.  Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial.

Authors:  R C Reichman; G J Badger; M E Guinan; A J Nahmias; R E Keeney; L G Davis; T Ashikaga; R Dolin
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

Review 7.  Acyclovir in the management of herpes labialis.

Authors:  J M Yeo; A P Fiddian
Journal:  J Antimicrob Chemother       Date:  1983-09       Impact factor: 5.790

8.  Successful treatment of herpes labialis with topical acyclovir.

Authors:  A P Fiddian; J M Yeo; R Stubbings; D Dean
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28

9.  Failure of topical acyclovir in ointment to penetrate human skin.

Authors:  D J Freeman; N V Sheth; S L Spruance
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

10.  Intracellular pools of thymidine reduce the antiviral action of acyclovir.

Authors:  J Harmenberg
Journal:  Intervirology       Date:  1983       Impact factor: 1.763
View more
  3 in total

1.  Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice.

Authors:  J Piret; A Désormeaux; H Cormier; J Lamontagne; P Gourde; J Juhász; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

2.  Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery.

Authors:  Nada Abla; Aarti Naik; Richard H Guy; Yogeshvar N Kalia
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

3.  Study of Antiherpetic Efficiency of Phosphite of Acycloguanosine Ableto Over come the Barrier of Resistance to Acyclovir.

Authors:  V L Andronova; M V Jasko; M K Kukhanova; G A Galegov; Yr S Skoblov; S N Kochetkov
Journal:  Acta Naturae       Date:  2016 Jan-Mar       Impact factor: 1.845
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.